Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Berton-Rigaud

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Bulletin Du Cancer|May 19, 2011
[Her2 positive breast cancer: practices]Mario Campone, Dominique Berton-Rigaud, Emmanuelle Bourbouloux, et al.
Bulletin Du Cancer|June 20, 2017
Anne Floquet, Dominique Berton-Rigaud, Gwenael Ferron, et al.
Journal of the American Geriatrics Society|May 16, 2014
Early death in advanced ovarian cancer in older adultsEloise Lefur, Dominique Berton-Rigaud, Anne S Boureau, et al.
Bulletin Du Cancer|February 2, 2011
[The role of interval surgery in the treatment's strategy of advanced ovarian cancer]Isabelle Jaffré, Virginie Bordes, Magali Dejode, et al.
Bulletin Du Cancer|March 20, 2016
[Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases]Jean-Sébastien Frenel, Olivia Bally, Emmanuelle Bourbouloux, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 23, 2018
Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Review of Anticancer Therapy|March 20, 2019
Pertuzumab for the treatment of breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Opinion on Pharmacotherapy|November 25, 2017
Efficacy of buparlisib in treating breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Drugs|August 26, 2018
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast CancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Therapeutic Advances in Medical Oncology|May 23, 2017
Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapyPaule Augereau, Anne Patsouris, Emmanuelle Bourbouloux, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|May 19, 2011
[Her2 positive breast cancer: practices]Mario Campone, Dominique Berton-Rigaud, Emmanuelle Bourbouloux, et al.
Bulletin Du Cancer|June 20, 2017
Anne Floquet, Dominique Berton-Rigaud, Gwenael Ferron, et al.
Journal of the American Geriatrics Society|May 16, 2014
Early death in advanced ovarian cancer in older adultsEloise Lefur, Dominique Berton-Rigaud, Anne S Boureau, et al.
Bulletin Du Cancer|February 2, 2011
[The role of interval surgery in the treatment's strategy of advanced ovarian cancer]Isabelle Jaffré, Virginie Bordes, Magali Dejode, et al.
Bulletin Du Cancer|March 20, 2016
[Trastuzumab emtansine in the systemic treatment of HER-2-positive breast cancer brain metastases]Jean-Sébastien Frenel, Olivia Bally, Emmanuelle Bourbouloux, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 23, 2018
Pharmacokinetic drug evaluation of abemaciclib for advanced breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Review of Anticancer Therapy|March 20, 2019
Pertuzumab for the treatment of breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Expert Opinion on Pharmacotherapy|November 25, 2017
Efficacy of buparlisib in treating breast cancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Drugs|August 26, 2018
An Update on the Clinical Use of CDK4/6 Inhibitors in Breast CancerMarie Robert, Jean-Sébastien Frenel, Emmanuelle Bourbouloux, et al.
Therapeutic Advances in Medical Oncology|May 23, 2017
Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapyPaule Augereau, Anne Patsouris, Emmanuelle Bourbouloux, et al.
Pageof 5